Overview

Rituximab in Pretreated Elderly or Unfit B-CLL Patients

Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The study will test the efficacy rituximab in addition to glucocorticoids for the treatment of B-CLL in elderly or unfit patients.
Phase:
Phase 2
Details
Lead Sponsor:
Prof. Dr. Med. Laimonas Griskevicius
Treatments:
Glucocorticoids
Methylprednisolone
Rituximab